If a woman’s lifetime risk for breast cancer is 20% or greater, the
American Cancer Society (ACS) and the
National Comprehensive Cancer Network state that annual breast
MRI screening is an option for her. It is important to note that breast MRI is not
a substitute for mammography. All women of screening age should continue with annual mammograms.
A patient may choose to have breast MRI at the same time as a mammogram or she may
alternate mammogram and MRI every six months. The patient and her referring physician(s) can
determine the schedule that is best. According to the ACS, there is no evidence to support
one approach over the other. Patients should discuss this option with their referring
physician(s). For more information on this topic, patients can contact our Risk Assessment and
Prevention Program at 720-493-3700 or via email at
RAPP@riaco.com.
If a patient is interested in breast MRI screening at Invision Sally Jobe, it is important that
she returns to her referring doctor(s) to review this information with him or her. Like all
procedures, breast MRI will require an order from a referring physician(s). After the order is faxed
to us, a member of our staff will contact the patient to schedule the procedure. Prior to the
appointment, we will work with the patient’s insurance company to ensure that the breast MRI
is pre-authorized.
Breast Cancer Risk Assessment
Access the Gail Breast Cancer Risk
Assessment Tool to assess your breast cancer risk. This user-friendly calculator will provide an
estimate of a woman’s breast cancer risk. Please note that in certain circumstances the Gail
model may under- or overestimate risk. For example, it may underestimate risk for patients who have a
family history of ovarian cancer or for those who have a family history of breast cancer in second-degree
relatives (i.e. aunts, grandmother). Additional models are available in these situations and patients
can request a more detailed breast cancer risk assessment through the Risk Assessment
and Prevention Program at Invision Sally Jobe.